Skyrizi Treats What Conditions? An Overview of Its Uses

Skyrizi is a medication used to treat certain inflammatory conditions, primarily prescribed for moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a biologic therapy that targets specific proteins involved in the inflammatory response.

Conditions Treated by Skyrizi

1. Plaque Psoriasis: Skyrizi is FDA-approved for treating moderate to severe plaque psoriasis in adults, a chronic autoimmune condition causing red, scaly patches on the skin. By reducing inflammation and skin cell turnover, Skyrizi helps patients achieve clearer skin.

2. Psoriatic Arthritis: Skyrizi is also used to treat psoriatic arthritis in adults, which affects some individuals with psoriasis. It can alleviate joint pain, swelling, and stiffness in patients with this condition.

3. Ankylosing Spondylitis: Skyrizi has been effective in treating ankylosing spondylitis, a type of arthritis primarily affecting the spine. By targeting the inflammatory response associated with this condition, Skyrizi can enhance mobility and reduce pain for affected individuals.

   Advertisement

How Skyrizi Works

Skyrizi targets a protein called interleukin-23 (IL-23) in the body, which is involved in the inflammatory response leading to autoimmune conditions like psoriasis and psoriatic arthritis. By blocking IL-23’s action, Skyrizi reduces inflammation and slows down disease progression.

Dosage and Administration

Skyrizi is typically administered as a subcutaneous injection by a healthcare provider. The recommended dose is 150 mg, given as two 75 mg injections at weeks 0 and 4, followed by a maintenance dose every 12 weeks. Adhering to the dosing schedule is crucial for optimal results.

Side Effects

Common side effects of Skyrizi include injection site reactions, upper respiratory tract infections, headache, fatigue, and diarrhea. Patients should promptly report any side effects to their healthcare provider, as some may require medical attention.

Conclusion

In conclusion, Skyrizi is a biologic therapy used to treat inflammatory conditions like plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. By targeting the inflammatory response, Skyrizi can reduce symptoms and enhance the quality of life for patients. It is essential for patients to collaborate closely with their healthcare provider to determine the suitability of Skyrizi as a treatment option and adhere to the recommended dosing schedule for optimal outcomes.

FAQ

1. What conditions does Skyrizi treat?

Skyrizi is primarily prescribed for the treatment of moderate to severe plaque psoriasis in adults, psoriatic arthritis, and ankylosing spondylitis.

1. How does Skyrizi work?

Skyrizi works by targeting a protein in the body called interleukin-23 (IL-23) which is involved in the inflammatory response that leads to autoimmune conditions like psoriasis and psoriatic arthritis. By blocking IL-23, Skyrizi helps reduce inflammation and slow down the progression of these conditions.

1. How is Skyrizi administered?

Skyrizi is typically administered as a subcutaneous injection given by a healthcare provider. The recommended dose is 150 mg, given as two 75 mg injections at weeks 0 and 4, followed by a maintenance dose every 12 weeks.

1. What are the common side effects of Skyrizi?

Common side effects of Skyrizi include injection site reactions (redness, swelling, pain), upper respiratory tract infections, and headaches.